Jiaoti Huang

Here are some of the DCI faculty, researchers, and clinical providers whose work has recently been featured in the media, trades, journals, at Duke and the DCI blog.

Here are some of the DCI faculty, researchers, and clinical providers whose work has recently been featured in the media, trades, journals, at Duke and the DCI blog.

Here are some of the DCI faculty, researchers, and clinical providers whose work has recently been featured in the media, trades, journals, at Duke and the DCI blog.

The Duke BioRepository & Precision Pathology Center, a Duke School of Medicine Service Center and DCI Shared Resource turns 10.

Learn how the Precision Cancer Medicine Initiative is advancing research, extending lives, and breaking down barriers to access.

Here are some of the DCI faculty, researchers, and clinical providers whose work has recently been featured by the media, academic trade publications & journals.

Duke Cancer Institute researchers Jiaoti Huang, MD, PhD, Brant Inman, MD, and Qing Cheng, PhD, have identified a molecular signature that can spot aggressive cells.

The finding points toward a new approach that directly targets the cancer’s fuel source.

DCI pathologist Jung Wook Park, PhD, mentored by Jiaoti Huang, MD, PhD, and Andrew Armstrong, MD, MSc, has received a Prostate Cancer Foundation Young Investigator Award.

The Duke Department of Pathology/Duke Clinical Labs has established the Division of Artificial Intelligence and Computational Pathology.

Here's a sample of some of the DCI physicians, physician-scientists, researchers and nurses whose work is featured by the media and in academic journals.

Here's a sample of some of the DCI physicians, physician-scientists, researchers and nurses whose work is featured by the media and in academic journals.

Drug tested in lab studies halts cancer cells that are impervious to hormone therapy.